Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor.
暂无分享,去创建一个
I. Lemmens | Anne-Sophie de Smet | J. Tavernier | J. Vandekerckhove | A. Verhee | F. Peelman | D. Lavens | I. Uyttendaele
[1] J. Tavernier,et al. Functional Cross-modulation between SOCS Proteins Can Stimulate Cytokine Signaling* , 2006, Journal of Biological Chemistry.
[2] S. Hubbard,et al. Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3. , 2006, Structure.
[3] Karl H. Clodfelter,et al. Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. , 2006, Molecular endocrinology.
[4] J. Tavernier,et al. A complex interaction pattern of CIS and SOCS2 with the leptin receptor , 2006, Journal of Cell Science.
[5] Stefan Knapp,et al. Crystal structure of the SOCS2–elongin C–elongin B complex defines a prototypical SOCS box ubiquitin ligase , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[6] R. Norton,et al. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. , 2006, Molecular cell.
[7] G. Norstedt,et al. Negative regulation of growth hormone receptor signaling. , 2006, Molecular endocrinology.
[8] S. Becker,et al. Structure of the Unphosphorylated STAT5a Dimer* , 2005, Journal of Biological Chemistry.
[9] D. Waxman,et al. Role of the Cytokine-induced SH2 Domain-containing Protein CIS in Growth Hormone Receptor Internalization* , 2005, Journal of Biological Chemistry.
[10] I. Lemmens,et al. A systematic scan of interactions with tyrosine motifs in the erythropoietin receptor using a mammalian 2-hybrid approach. , 2005, Blood.
[11] B. Blom,et al. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression , 2005, Nature Immunology.
[12] Claes Ohlsson,et al. SOCS2 negatively regulates growth hormone action in vitro and in vivo. , 2005, The Journal of clinical investigation.
[13] R. Teasdale,et al. In Vivo Analysis of Growth Hormone Receptor Signaling Domains and Their Associated Transcripts , 2005, Molecular and Cellular Biology.
[14] Keiichi I Nakayama,et al. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. , 2004, Genes & development.
[15] B. Little,et al. Growth hormone insensitivity associated with a STAT5b mutation. , 2003, The New England journal of medicine.
[16] Jan Tavernier,et al. Heteromeric MAPPIT: a novel strategy to study modification-dependent protein-protein interactions in mammalian cells. , 2003, Nucleic acids research.
[17] W. Alexander,et al. Biological Evidence That SOCS-2 Can Act Either as an Enhancer or Suppressor of Growth Hormone Signaling* , 2002, The Journal of Biological Chemistry.
[18] S. Asa,et al. Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). , 2002, Molecular endocrinology.
[19] Jan Tavernier,et al. Design and application of a cytokine-receptor-based interaction trap , 2001, Nature Cell Biology.
[20] J. Turkson,et al. Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation* , 2001, The Journal of Biological Chemistry.
[21] T. Zhu,et al. Signal transduction via the growth hormone receptor. , 2001, Cellular signalling.
[22] D. Waxman,et al. Role of the Cytokine-inducible SH2 Protein CIS in Desensitization of STAT5b Signaling by Continuous Growth Hormone* , 2000, The Journal of Biological Chemistry.
[23] J. Tavernier,et al. Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor , 2000, FEBS letters.
[24] J. Kopchick,et al. Growth hormone (GH), GH receptor, and signal transduction. , 2000, Molecular genetics and metabolism.
[25] W. Alexander,et al. Gigantism in mice lacking suppressor of cytokine signalling-2 , 2000, Nature.
[26] D. Waxman,et al. SOCS/CIS Protein Inhibition of Growth Hormone-stimulated STAT5 Signaling by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.
[27] M. Kubo,et al. Suppression of STAT5 Functions in Liver, Mammary Glands, and T Cells in Cytokine-Inducible SH2-Containing Protein 1 Transgenic Mice , 1999, Molecular and Cellular Biology.
[28] J. G. Zhang,et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] W. Alexander,et al. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL‐6 signal transduction , 1999, The EMBO journal.
[30] T. Naka,et al. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] S. Becker,et al. Three-dimensional structure of the Stat3β homodimer bound to DNA , 1998, Nature.
[32] L. Mathews,et al. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling , 1997, Molecular and cellular biology.
[33] J. Schwartz,et al. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B. , 1997, Endocrinology.
[34] R. Snell,et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[35] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.
[36] P. Heinrich,et al. Comparative study on the phosphotyrosine motifs of different cytokine receptors involved in STAT5 activation , 1996, FEBS letters.
[37] P. Kelly,et al. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. , 1996, Molecular endocrinology.
[38] J. Nielsen,et al. Identification of Tyrosine Residues in the Intracellular Domain of the Growth Hormone Receptor Required for Transcriptional Signaling and Stat5 Activation (*) , 1996, The Journal of Biological Chemistry.
[39] D. Meyer,et al. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. , 1996, Molecular endocrinology.
[40] William I. Wood,et al. Growth hormone receptor and serum binding protein: purification, cloning and expression , 1987, Nature.
[41] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[42] J. Tavernier,et al. The C-terminus of CIS defines its interaction pattern. , 2007, The Biochemical journal.
[43] J. Kopchick,et al. Growth hormone (GH) receptor knockout mice reveal actions of GH in lung development , 2006, Proteomics.
[44] A. Yoshimura,et al. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation. , 2003, Journal of biochemistry.
[45] J. Kopchick,et al. Transgenic models of growth hormone action. , 1999, Annual review of nutrition.